SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001262463-14-001090
Filing Date
2014-11-14
Accepted
2014-11-14 16:19:27
Documents
10
Period of Report
2014-09-30

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q plplq.htm 10-Q 215220
2 EXHIBIT 31.1 ex311.htm EX-31 7961
3 EXHIBIT 31.2 ex312.htm EX-31 7957
4 EXHIBIT 32 ex321.htm EX-32 4192
  Complete submission text file 0001262463-14-001090.txt   2508732

Data Files

Seq Description Document Type Size
5 XBRL INSTANCE FILE plpl-20140930.xml EX-101.INS 247164
6 XBRL SCHEMA FILE plpl-20140930.xsd EX-101.SCH 28621
7 XBRL CALCULATION FILE plpl-20140930_cal.xml EX-101.CAL 46615
8 XBRL DEFINITION FILE plpl-20140930_def.xml EX-101.DEF 111212
9 XBRL LABEL FILE plpl-20140930_lab.xml EX-101.LAB 189763
10 XBRL PRESENTATION FILE plpl-20140930_pre.xml EX-101.PRE 174219
Mailing Address 1451 NORTH 200 EAST SUITE #130C LOGAN UT 98102
Business Address 1451 NORTH 200 EAST SUITE #130C LOGAN UT 98102 801-209-1227
Plandai Biotechnology, Inc. (Filer) CIK: 0001317880 (see all company filings)

IRS No.: 453642179 | Fiscal Year End: 0630
Type: 10-Q | Act: 34 | File No.: 000-51206 | Film No.: 141224446
SIC: 2834 Pharmaceutical Preparations